Showing 161 - 180 results of 41,496 for search '(( 50 ((((teer decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 01 1 decrease ))', query time: 0.72s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165

    Fatigue of the wrist extensor muscles decreases palmar grip strength by Vitor Kinoshita Souza (10420550)

    Published 2021
    “…The fatigue protocol was effective on hand grip strength reduction (43.5±3.85 kgf in baseline and 36.50±5.1 kgf final) and lateral pinch strength reduction (10.26±1.01 kgf in baseline and 8.54±0.86 kgf final) (p<0.05, 95% CI). …”
  6. 166
  7. 167

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
  8. 168

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  9. 169
  10. 170

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  11. 171

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  12. 172
  13. 173

    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1<... by Lucheng Li (13753395)

    Published 2023
    “…Besides, the electrochemical properties of the batteries during cold conditions can be obviously improved by adding EB. In addition, after 50 cycles of −40 °C, the basic electrolyte has a discharge capacity of 81.94 mAh g<sup>–1</sup>; on the contrary, the cells using the 16 EB-modified coreagent maintains a discharge capacity of 112.3 mAh g<sup>–1</sup> under the same conditions. …”
  14. 174

    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1<... by Lucheng Li (13753395)

    Published 2023
    “…Besides, the electrochemical properties of the batteries during cold conditions can be obviously improved by adding EB. In addition, after 50 cycles of −40 °C, the basic electrolyte has a discharge capacity of 81.94 mAh g<sup>–1</sup>; on the contrary, the cells using the 16 EB-modified coreagent maintains a discharge capacity of 112.3 mAh g<sup>–1</sup> under the same conditions. …”
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180